Why Rossari Biotech Is Confident Its New Deal Will Pay Off
Rossari Biotech Ltd. expects growth to accelerate following its acquisition of peer specialty chemical maker Unitop Chemicals Pvt. and the commissioning of a greenfield facility at Dahej, Gujarat.
The acquisition, announced on June 2, will help scale up the company's overseas shipments, given Unitop's export-faced business, Edward Menez, founder and chief executive officer of Rossari Biotech, told BloombergQuint's Niraj Shah in an interview.
Unitop Chemicals makes surfactants, emulsifiers and specialty chemicals at its three sites with a total capacity of 86,000 metric tonnes per annum and a saleable capacity of 30,000-40,000 MTPA, currently operating at 65-70% utilisation, Menez said. Its products are largely formulations and it makes many of its ingredients in-house for captive consumption, much like Rossari Biotech, which went public last year.
He sees the complementary business models of the two companies building a stronger operating presence. That includes cross-selling opportunities, and Rossari Biotech taking advantage of Unitop's lower utilisation levels and increasing growth in FY22 itself.
Menez refrained from offering overall guidance for Rossari's growth in FY22, but said that an organic growth of over 30% and an increase in Unitop's revenue of around Rs 300 crore is possible in the ongoing fiscal itself.
Rossari Biotech's revenue rose 18% year-on-year to Rs 709 crore in the year ended March, while profit rose by around 25% to Rs 81 crore.
Brokerage View
Edelweiss Wealth said Unitop's expertise in surfactants is in sync with Rossari's focus areas and the acquisition should see synergies emerge from an expanded product portfolio, cross-selling opportunities, increased technology and market reach.
The acquisition, the brokerage said, will be EPS accretive for Rossari.
It maintained a ‘Buy' rating on the company with revised target price of Rs 1,447 apiece, implying an upside of 12.5%.
Rich valuations can impact the near-term upside, Edelweiss said.
Watch the full interaction here:
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.